Name | N,N-dimethyl-N'-(pyridin-3-ylmethyl)-N'-[4-[2,4,6-tri(propan-2-yl)phenyl]-1,3-thiazol-2-yl]ethane-1,2-diamine |
---|---|
Synonyms | MFCD00904759 |
Description | Foropafant (SR27417) highly potent, competitive, selective and orally active antagonist of platelet-activating factor (PAF) receptor, with a Ki value of 57 pM for [3H]PAF binding, at least 5-fold lower than that of unlabeled PAF itself. Foropafant potently inhibits PAF-induced aggregation of rabbit and human platelets[1]. |
---|---|
Related Catalog | |
Target |
Ki: 57 pM ([3H]PAF binding)[1] |
References |
Density | 1.065g/cm3 |
---|---|
Boiling Point | 571.6ºC at 760mmHg |
Molecular Formula | C28H40N4S |
Molecular Weight | 464.70900 |
Flash Point | 299.5ºC |
Exact Mass | 464.29700 |
PSA | 60.50000 |
LogP | 7.14350 |
Vapour Pressure | 4.49E-13mmHg at 25°C |
Index of Refraction | 1.575 |
Storage condition | -20°C |
Hazard Codes | Xi |
---|---|
RIDADR | NONH for all modes of transport |